Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive (Loss) Income
Total
BALANCE at Dec. 31, 2020 $ 23 $ 844,188 $ (328,277) $ (9) $ 515,925
BALANCE (in shares) at Dec. 31, 2020 224,626,597        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of Common Stock options   3,665     3,665
Exercise of Common Stock options (in shares) 2,846,734        
Vesting of restricted Common Stock (in shares) 112,030        
Vesting of restricted stock units (in shares) 43,921        
Net settlement of shares for employee tax withholdings upon vesting of restricted stock units (in shares) (9,172)        
Repurchase of shares for employee tax withholdings   (145)     (145)
Issuance of Common Stock for acquisitions $ 1 208,988     208,989
Issuance of Common Stock for acquisitions (in shares) 9,049,338        
Issuance of common stock for acquired in-process research and development   4,300     4,300
Issuance of common stock for acquired in-process research and development (in shares) 334,370        
Stock-based compensation expense   6,216     6,216
Vesting of Trine Founder shares (in shares) 1,850,938        
Exercise of warrants $ 2 320,567     320,569
Exercise of warrants (in shares) 20,690,975        
Net loss     (102,288)   (102,288)
Other comprehensive income (loss)       113 113
BALANCE at Jun. 30, 2021 $ 26 1,387,779 (430,565) 104 957,344
BALANCE (in shares) at Jun. 30, 2021 259,545,731        
BALANCE at Dec. 31, 2020 $ 23 844,188 (328,277) (9) 515,925
BALANCE (in shares) at Dec. 31, 2020 224,626,597        
BALANCE at Dec. 31, 2021 $ 31 1,823,344 (568,611) (6,414) 1,248,350
BALANCE (in shares) at Dec. 31, 2021 311,473,950        
BALANCE at Mar. 31, 2021 $ 25 1,326,945 (387,385) (21) 939,564
BALANCE (in shares) at Mar. 31, 2021 252,436,919        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of Common Stock options   3,485     3,485
Exercise of Common Stock options (in shares) 2,683,506        
Vesting of restricted Common Stock (in shares) 56,015        
Vesting of restricted stock units (in shares) 28,656        
Net settlement of shares for employee tax withholdings upon vesting of restricted stock units (in shares) (6,931)        
Repurchase of shares for employee tax withholdings   (91)     (91)
Issuance of Common Stock for acquisitions $ 1 49,141     49,142
Issuance of Common Stock for acquisitions (in shares) 4,013,196        
Issuance of common stock for acquired in-process research and development   4,300     4,300
Issuance of common stock for acquired in-process research and development (in shares) 334,370        
Stock-based compensation expense   3,999     3,999
Net loss     (43,180)   (43,180)
Other comprehensive income (loss)       125 125
BALANCE at Jun. 30, 2021 $ 26 1,387,779 (430,565) 104 957,344
BALANCE (in shares) at Jun. 30, 2021 259,545,731        
BALANCE at Dec. 31, 2021 $ 31 1,823,344 (568,611) (6,414) 1,248,350
BALANCE (in shares) at Dec. 31, 2021 311,473,950        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of Common Stock options   1,264     1,264
Exercise of Common Stock options (in shares) 1,021,000        
Vesting of restricted Common Stock (in shares) 113,555        
Vesting of restricted stock units $ 1       1
Vesting of restricted stock units (in shares) 2,483,111        
Net settlement of shares for employee tax withholdings upon vesting of restricted stock units (in shares) (56,141)        
Repurchase of shares for employee tax withholdings   (189)     (189)
Issuance of Common Stock related to settlement of contingent consideration   500     500
Issuance of Common Stock related to settlement of contingent consideration (in shares) 112,202        
Stock-based compensation expense   26,917     26,917
Net loss     (367,216)   (367,216)
Other comprehensive income (loss)       (38,487) (38,487)
BALANCE at Jun. 30, 2022 $ 32 1,851,836 (935,827) (44,901) 871,140
BALANCE (in shares) at Jun. 30, 2022 315,147,677        
BALANCE at Mar. 31, 2022 $ 31 1,833,998 (638,555) (17,449) 1,178,025
BALANCE (in shares) at Mar. 31, 2022 312,825,572        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of Common Stock options   364     364
Exercise of Common Stock options (in shares) 234,307        
Vesting of restricted Common Stock (in shares) 29,171        
Vesting of restricted stock units $ 1       1
Vesting of restricted stock units (in shares) 1,962,846        
Net settlement of shares for employee tax withholdings upon vesting of restricted stock units   (31)     (31)
Net settlement of shares for employee tax withholdings upon vesting of restricted stock units (in shares) (16,421)        
Issuance of Common Stock related to settlement of contingent consideration   500     500
Issuance of Common Stock related to settlement of contingent consideration (in shares) 112,202        
Stock-based compensation expense   17,005     17,005
Net loss     (297,272)   (297,272)
Other comprehensive income (loss)       (27,452) (27,452)
BALANCE at Jun. 30, 2022 $ 32 $ 1,851,836 $ (935,827) $ (44,901) $ 871,140
BALANCE (in shares) at Jun. 30, 2022 315,147,677